News

  Nijmegen, NL – January 17, 2022 – Vaxxinova proudly presents its brand new corporate video. It gives an impression on our commitment to animal health, animal welfare and one health. Vaxxinova, we care.  

Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […]

May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH,  will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]

March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine.  Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens.  Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]

Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]

Nijmegen, The Netherlands, Friday January 17, 2020. In January 2020, Vaxxinova will be present at the IPPE 2020 trade show in Atlanta. Our team is ready to meet you at booth C10361. The show is open to visitors on Tue Jan 28 (10 AM – 5 PM), Wed Jan 29 (9AM – 5PM), Thu Jan […]